FDA and CMS Approve of Exact Science’s Cologuard

FDA and CMS Approve of Exact Science’s Cologuard

 

unnamed
FDA and CMS Approve of Exact Science’s Cologuard

In a first, on the very same day that FDA announced approval of a new test called Cologuard, which detects 92% of cancer and 69% of advanced pre-cancer, CMS approved its intention to cover the test for Medicare. This was the first item to go through parallel review by FDA and CMS. It is remarkable that literally on the same day that FDA announced its approval that CMS announced its intention to cover the test.

It is an excellent example on how government can be changed to introduce new technologies in this case a molecular diagnostics into the heath care system quickly.

 

Leave a Reply

Your email address will not be published. Required fields are marked *